Neuroblastoma Market Forecast – Upcoming Therapies Expected to Shift the Market Towards Immunotherapy
Neuroblastoma originates in adrenal medulla and paraspinal or periaortic regions, where sympathetic nervous system tissue is present. It is the third most common childhood cancer, after leukemia and brain tumors, and is the most common solid extracranial tumor in children. Neuroblastoma is staged by the two systems that are INSS and INRGSS. Neuroblastoma cancer occurs most often in infants and young children, and is rarely found in children older than 10 years.
View full press release